GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ModivCare Inc (NAS:MODV) » Definitions » Intrinsic Value: Projected FCF
中文

ModivCare (ModivCare) Intrinsic Value: Projected FCF

: $73.68 (As of Today)
View and export this data going back to 2003. Start your Free Trial

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-24), ModivCare's Intrinsic Value: Projected FCF is $73.68. The stock price of ModivCare is $22.52. Therefore, ModivCare's Price-to-Intrinsic-Value-Projected-FCF of today is 0.3.

The historical rank and industry rank for ModivCare's Intrinsic Value: Projected FCF or its related term are showing as below:

MODV' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.31   Med: 1.45   Max: 2.13
Current: 0.31

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of ModivCare was 2.13. The lowest was 0.31. And the median was 1.45.

MODV's Price-to-Projected-FCF is ranked better than
93.77% of 305 companies
in the Healthcare Providers & Services industry
Industry Median: 1.28 vs MODV: 0.31

ModivCare Intrinsic Value: Projected FCF Historical Data

The historical data trend for ModivCare's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ModivCare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.50 65.07 96.39 108.17 73.68

ModivCare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.17 93.10 65.19 81.38 73.68

Competitive Comparison

For the Medical Care Facilities subindustry, ModivCare's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ModivCare Price-to-Projected-FCF Distribution

For the Healthcare Providers & Services industry and Healthcare sector, ModivCare's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where ModivCare's Price-to-Projected-FCF falls into.



ModivCare Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get ModivCare's Free Cash Flow(6 year avg) = $61.93.

ModivCare's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec23)*0.8)/Shares Outstanding (Diluted Average)
=(14.862653310476*61.92784+156.195*0.8)/14.187
=73.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ModivCare  (NAS:MODV) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

ModivCare's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=22.52/73.684923957611
=0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ModivCare Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of ModivCare's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


ModivCare (ModivCare) Business Description

Traded in Other Exchanges
Address
6900 Layton Avenue, 12th Floor, Denver, CO, USA, 80237
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
Executives
Barbara Gutierrez officer: Chief Financial Officer 8950 E. LOWRY BLVD., DENVER CO 80230
L Heath Sampson officer: Chief Financial Officer C/O ADVANCED EMISSIONS SOLUTIONS, INC., 9135 S RIDGELINE BLVD STE 200, HIGHLANDS RANCH CO 80129
Coliseum Capital Management, Llc director, 10 percent owner 105 ROWAYTON AVENUE, ROWAYTON CT 06853
Henry Toledo officer: Chief People Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Jessica Kral officer: Chief Information Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Anne E, Bailey officer: President, Home Division 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Rebecca Orcutt officer: VP, Chief Accounting Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Brett M. Hickman officer: Chief Commercial Officer 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Ilias Simpson officer: President, Transportation 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Jason E Anderson officer: President of ModivCare Home 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Grover Wray officer: Chief Human Resources Officer DIGITALGLOBE, INC., 1300 WEST 120TH AVENUE, WESTMINSTER CO 80234
Daniel E Greenleaf director, officer: CEO and President C/O NABI BIO PHARMACEUTICALS, 5800 PARK OF COMMERCE BLVD., N.W., BOCA RATON FL 33487
Jonathan B Bush officer: SVP, GC and Secretary 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Kenneth Shepard officer: Vice President, CAO 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Stacy Saal director 4700 SOUTH SYRACUSE STREET, 4TH FLOOR, DENVER CO 80237